Aurinia Pharmaceuticals
在场
高管
查看带有其 15 名主要高管的组织结构图
Aurinia Pharmaceuticals 搜索最多的简介
高管在Aurinia Pharmaceuticals变化
- Craig Johnson已作为Director加入公司 (新闻发布的2024十一月8号).
- Robert Foster, Director, 正在办理退休 (新闻发布的2024十一月8号).
- Kevin Tang已作为Director加入公司 (新闻发布的2024九月13号).
创建提醒
跟踪 Aurinia Pharmaceuticals 的高管变动
药店
Aurinia Pharmaceuticals 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
Aurinia Pharmaceuticals 的最新新闻稿
- Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
- Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
- Aurinia to Participate in Jefferies London Healthcare Conference
- Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
- Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development
- Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024
- Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis
- Aurinia Announces Board Restructuring
- Press Releases
- Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference
- View more press releases Close
通过电子邮件
